|Day's Range||33.75 - 33.94|
|52 Week Range||29.83 - 37.39|
|PE Ratio (TTM)||28.92|
|Dividend & Yield||1.28 (3.78%)|
|1y Target Est||N/A|
Private-equity firms and other investors are funding late-stage clinical trials, shouldering the risk for pharmaceutical companies like Pfizer in exchange for a share of the upside if a drug succeeds.
24/7 Wall St. has put together a preview of Apple, Facebook, Pfizer and some of the other top companies reporting their latest results in the coming week.
These factors could make the difference in whether Pfizer meets expectations in Q1.